Zy Therapeutics
- Biotech or pharma, therapeutic R&D
Zy Therapeutics is a drug development company that focuses on disease-modifying therapeutics to treat rare and unmet medical needs for neurological disorders including epilepsy.
Zy Therapeutics is developing Kamini® Oral Powder as a disease-modifying treatment for Sturge-Weber Syndrome, a rare, intractable epilepsy syndrome that currently has no treatments.
We are currently raising funds to complete our reformulation and to initiate clinical trials in close cooperation with patient advocacy groups.